Industry Supported Satellite Symposia Schedule

Tuesday, April 13, 2027: 4:00 PM – 5:30 PM
Minneapolis Convention Center: M100 ABCHIJ

Navigating Genomic Testing: From Reflex Assays to Rapid Long-read Whole Genome Sequencing

This session explores how clinical context should guide genomic assay selection. Speakers will discuss reflex testing, targeted panels, and long-read whole-genome sequencing—including rapid approaches for inherited, rare disease and critical cases.

Learning Objectives:

• The value of a whole genome sequencing approach, especially rapid

• Growing awareness of long-read targeted sequencing

• Providing case examples per the above

Faculty: 
Sebastian Lunke, PhD, VCGS, Translational Genomics Research Group, MCRI
Devin Oglesbee, PhD, Mayo Clinic
Cora Vacher, PhD, Oxford Nanopore Technologies

Non-accredited

For more information and to register: Coming Soon

Tuesday, April 13, 2027: 4:00 PM – 5:30 PM
Minneapolis Convention Center: M100 DEFG

SLOS and FOP Across the Lifespan: From Recognition to Long-Term Care

Rare genetic disorders such as Smith-Lemli-Opitz syndrome and fibrodysplasia ossificans progressiva can present significant challenges throughout the patient journey, from initial recognition and diagnosis to long-term disease management. This non-CME, industry-supported symposium will explore the clinical characteristics, disease burden, functional limitations, and care transitions associated with SLOS and FOP.

Learning Objectives:

• Recognize key early clinical features of SLOS and FOP to support earlier diagnosis and improved patient management
• Examine the lifelong experiences of individuals with SLOS and FOP, including disease burden, functional limitations, and care needs through real-world clinical experience and patient-centered perspectives.
• Recognize the complexities of delivering coordinated, patient-centered care for individuals living with rare genetic disorders.

Faculty:
Paul Hillman, MD, PhD, Children’s Memorial Hermann Hospital
Angela Cheung, MD, University of Toronto
Edwin (Clay) Ferren, MD, Atrium Health Children’s Hospital

Non Accredited

For more information and to register: Coming Soon

Tuesday, April 13, 2027: 4:00 PM – 5:30 PM
Minneapolis Convention Center: Ballroom B

Hypochondroplasia: Improved recognition, timely diagnosis and targeted care

Often overlooked or diagnosed late, hypochondroplasia can affect health, function, quality of life, and daily living. This program reviews key diagnostic clues, the role of genetic testing, underlying disease biology, and care considerations that may help clinicians recognize patients earlier and optimize management.

Learning Objectives:

• Understand the clinical impact and underlying cause of hypochondroplasia
• Learn to recognize the diagnostic red flag and role of genetic testing
• Discuss the importance of individualized care from a multidisciplinary team

Faculty

TBD

Non-Accredited

For more information and to register:  Coming Soon

Tuesday, April 13, 2027: 4:00 PM – 5:30 PM
Minneapolis Convention Center: 103 A-F

Improving Clinical Care with Newborn Screening: Predicting Care Pathways for Leukodystrophy

Will discuss clinical care for the various subtypes of metachromatic leukodystrophy (MLD) following a positive newborn screen. The event aims to enhance understanding of the clinical and psychosocial implications of implementing newborn screening for MLD including genotype-phenotype correlation for MLD and care pathways for MLD newborn screening patients.

Learning Objectives:

• Summarize published recommendations and best practices for predicting phenotype of a screen positive for MLD based on genotype
• Discuss unique genetic counseling and psychosocial considerations for screen positives for MLD
• Review recommended care pathways for screen positives for MLD based on predicted phenotype

Faculty
Amy Gaviglio, MS, CGC, Connetics Consulting
Josh Baker, DO, FACMG, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine
Rachel Hickey, MS, CGC, Ann & Robert H. Lurie Children’s Hospital of Chicago

Non-Accredited

For more information and to register 

Tuesday, April 13, 2027: 6:15 PM – 7:45 PM
Minneapolis Convention Center: M100 ABCHIJ

Flexible Sample Automation from Extraction to Pooled Library

Clinical genomics laboratories face varying sample volumes and diverse workflow requirements. Discover how flexible automation can simplify laboratory operations, from nucleic acid extraction through pooled library preparation. With 1–32-sample loading and integrated workflow capabilities, laboratories can adapt automation to changing sample volumes while reducing manual intervention.

Learning Objectives:

• Understand how flexible 1–32-sample loading can adapt to varying sample volumes.
• Explore an integrated workflow from nucleic acid extraction to pooled library preparation.
• Learn how flexible automation can reduce manual steps and support scalable laboratory workflows.

Faculty:
TBD

Non-Accredited

For more information and to register:  Coming Soon

Tuesday, April 13, 2027: 6:15 PM – 7:45 PM
Minneapolis Convention Center: 103 A-F

Communicating Evidence for Informed Treatment Decisions in Achondroplasia

This symposium will examine the breadth and clinical relevance of available evidence in achondroplasia, including outcomes and long-term data. Faculty will highlight the importance of early management and demonstrate evidence-based communication and counseling strategies to support informed treatment discussions with patients and caregivers.

Learning Objectives:

• Review the breadth of available clinical evidence in achondroplasia, including the outcomes evaluated and duration of available data.
• Discuss the clinical relevance of available evidence, including the importance of early management and implications for long-term outcomes.
• Apply evidence-based communication and counseling approaches to support informed treatment 2 discussions with patients and families.

Faculty:
TBD

Non-Accredited

For more information and to register:  Coming Soon

Wednesday, April 14, 2027: 8:00 AM - 9:30 AM
Minneapolis Convention Center: Ballroom B

Organic Acidemias in the Genomic Era: Resolving Complex Cases in Propionic and Methylmalonic Acidemias

This CME activity will provide geneticists with a case-based review of propionic acidemia and methylmalonic acidemia, emphasizing advances in diagnosis, genomic and metabolomic technologies, genotype-phenotype correlations, and evidence-based management. Interactive cases across the lifespan will prepare learners to optimize diagnosis, treatment, and long-term patient outcomes.

Learning Objectives:

• Analyze the molecular and biochemical mechanisms underlying Propionic Acidemia and
• Methylmalonic Acidemia and how they disrupt metabolic pathways
• Integrate genomic, metabolomic, and functional data to resolve complex diagnoses and variants of uncertain significance (VUS)
• Evaluate the clinical progression and multisystem complications of organic acidemias to guide 2 lifelong, evidence-based management
• Apply current and emerging therapeutic approaches including dietary management, organ-specific interventions, and gene-based therapies to optimize patient care

Faculty:
Ljubica Caldovic, PhD, Children's National Hospital; The George Washington University School of Medicine and Health Sciences; 
Kimberly A. Chapman, MD, PhD, University of Southern California; Children’s Hospital Los Angeles
Andrea Gropman, MD, St Jude Children’s Research Hospital

Accredited

For more information and to register:  Coming Soon

Wednesday, April 14, 2027: 8:00 AM - 9:30 AM
Minneapolis Convention Center: M100 ABCHIJ

Now Approved: The First and Only Oral Therapy for Achondroplasia

This 90-minute, non-CME symposium will feature two clinical genetics experts discussing the evolving treatment landscape in achondroplasia and the now approved oral FGFR3‑targeted therapy, infigratinib. Faculty will review disease biology, infigratinib mechanism of action, key efficacy and safety data, dosing and administration, and patient support, followed by audience Q&A.

Learning Objectives:

• Achondroplasia overview and MOD
• Infigratinib INDICATION
• MOA of infigratinib: targeting overactive FGFR3 signaling in achondroplasia

Faculty:
Julie Hoover-Fong, MD, PhD. Greenburg Center for Skeletal Dysplasia 

Non-Accredited

For more information and to register:  Coming Soon

Wednesday, April 14, 2027: 8:00 AM - 9:30 AM
Minneapolis Convention Center: M100 DEFG

Advancements in Rett Syndrome (RTT) Care: Caregiver and Expert Panel Discussion

Discussion on Rett Syndrome (RTT), a rare, complex neurodevelopmental disorder and an FDA-approved treatment option.

Learning Objectives:

• Review RTT diagnostic criteria and multisystem impact
• Examine clinical trial data from LAVENDER, LILAC-1, and LILAC-2, and real-world observations from the LOTUS post approval study
• Discover caregiver insights based on their experiences with RTT and DAYBUE

Faculty:
TBD

Non-Accredited

For more information and to register:  Coming Soon

Wednesday, April 14, 2027: 8:00 AM - 9:30 AM
Minneapolis Convention Center: 103 A-F

Not All Obesity Is the Same: A Look at Obesities caused by Rare Neuro-endocrine Diseases

Most clinicians think of obesity as a common, multifactorial disease — but not all obesity follows the same biology. Apart from lifestyle or typical metabolic factors, severe obesity can also be driven by impairment of the leptin–melanocortin-4 receptor (MC4R) pathway in the hypothalamus.

Learning Objectives:
TBD

Faculty
TBD

Non-Accredited

For more information and to register:  Coming Soon